SCHEMBL10129965

SCHEMBL10129965

CC(C)(C)OC(=O)Nc1cc(-c2cc(C(F)(F)F)ccc2F)ccn1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PIK3C3 Q8NEB9 2/20 0.43
AR P10275 1/20 0.41
SORT1 Q99523 1/20 0.41
TNIK Q9UKE5 1/20 0.41
ALDH1A1 P00352 1/20 0.41
GAA P10253 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
AAK1 Q2M2I8 4/20 0.41
IRAK4 Q9NWZ3 1/20 0.40
BRAF P15056 3/20 0.40
KDR P35968 2/20 0.40
RXFP1 Q9HBX9 1/20 0.40
CYP3A4 P08684 2/20 0.39
LCLAT1 Q6UWP7 1/20 0.39
CTSA P10619 1/20 0.39
TGFBR1 P36897 1/20 0.39
ALOX5AP P20292 1/20 0.39
FEN1 P39748 1/20 0.39
FFAR4 Q5NUL3 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL325900 0.83 SORT1 (0.48) PIK3C3SORT1ALDH1A1GAAL3MBTL1
SCHEMBL17971420 0.81 PIK3C3 (0.48) PIK3C3AAK1IRAK4CYP3A4TGFBR1
SCHEMBL30482567 0.79 KDM4E (0.40) PIK3C3TNIKALDH1A1AAK1IRAK4
SCHEMBL26206242 0.79 KDM4E (0.40) PIK3C3TNIKALDH1A1AAK1IRAK4
SCHEMBL5354912 0.78 MAPK14 (0.47) PIK3C3IRAK4RXFP1CYP3A4TGFBR1
SCHEMBL28757702 0.78 IRAK4 (0.40) PIK3C3AAK1IRAK4CYP3A4TGFBR1
SCHEMBL1104982 0.77 RIPK3 (0.44) PIK3C3AAK1IRAK4TGFBR1
SCHEMBL25358000 0.77 RXFP1 (0.48) RXFP1ALOX5APFEN1FFAR4
SCHEMBL5352411 0.76 GSK3B (0.45) PIK3C3AAK1IRAK4CYP3A4TGFBR1
SCHEMBL5349844 0.76 TGFBR1 (0.40) PIK3C3AAK1IRAK4TGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096558-B2 N-sulfonylbenzamide compounds PFIZER LIMITED (GB) 2015-08-04 US disclosed
US-9096558-B2 N-sulfonylbenzamide compounds PFIZER LIMITED (GB) 2015-08-04 US disclosed
EP-2590957-B1 N-SULFONYLBENZAMIDES AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS PFIZER LTD (GB) 2014-11-12 EP disclosed
US-20130109696-A1 Chemical Compounds PFIZER LIMITED (GB) 2013-05-02 US disclosed
US-20130109696-A1 Chemical Compounds PFIZER LIMITED (GB) 2013-05-02 US disclosed
WO-2012004714-A2 CHEMICAL COMPOUNDS PFIZER LIMITED (GB) 2012-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130109696-A1 Chemical Compounds SCN1A, SCN7A, SCN1B PIK3C3 1984/4885AR 2942/4885SORT1 2194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.